Tocilizumab in patients with multisystem Erdheim–Chester disease

Treatment of Erdheim–Chester disease (ECD), a rare non-Langerhans histiocytosis, relies on interferon-α, chemotherapeutic agents such as purine analogs, cytokine-blocking agents and BRAF inhibitors. Since interleukin (IL)-6 levels are elevated in serum and lesions of ECD patients, we evaluated the t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Berti, Alvise, Cavalli, Giulio, Guglielmi, Barbara, Biavasco, Riccardo, Campochiaro, Corrado, Tomelleri, Alessandro, Nicoletti, Roberto, Panzacchi, Andrea, Ferrarini, Marina, Dagna, Lorenzo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2017
Pynciau:
Brief Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486186/
https://ncbi.nlm.nih.gov/pubmed/28680751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1318237
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg